AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle
The new capital is expected to fund the company through 2029
The financing includes a four-year interest-only period, extendable to five years if a net sales milestone is achieved
The company has achieved a turnover of around Rs 100 crore in FY 2025–26 and aims to achieve a turnover of Rs 500 crore in next three years
The company’s broader OX2R portfolio includes clinical and preclinical assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions
Subscribe To Our Newsletter & Stay Updated
